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ABSTRACT
Aspirin-induced asthma is often accompanied by 
nasal polyps, in which tissue eosinophils are abundant 
and activated. However, the mechanism of eosinophil 
infiltration remains unknown. We encountered two 
aspirin-induced asthma patients with nasal polyps and 
investigated eosinophil infiltration into nasal polyp 
tissue. Eosinophil chemotactic activity of extracts from
the nasal polyp was elevated and could be inhibited by 
40% with anti-interleukin (IL)-5 antibody. Interleukin-5 
was detectable in the extract. The chemotactic 
activity of peripheral blood eosinophils to recombinant 
human (rh) IL-5 was increased compared with normal 
volunteers. Messenger RNA expression for IL-5 in
CD3+ lymphocytes for polyp tissue was detected using 
the reverse transcription-polymerase chain reaction. 
These results suggest that IL-5 from local T 
lymphocytes may be one of the candidates for 
recruitment of eosinophils into nasal polyps in aspirin-
induced asthma.
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INTRODUCTION
Aspirin-induced asthma is a variant of an intrinsic 
asthma associated with intolerance of aspirin and/or 
non-steroidal anti-inflammatory drugs (NSAID). Nasal
polyposis, with abundant tissue eosinophils, is a 
frequent finding in aspirin-induced asthma.1,2 A recent 
immunocytochemical study has demonstrated that 
eosinophils infiltrating nasal polyps are activated 
(EG2+).3 However, the mechanism of eosinophil 
infiltration into nasal polyps is unclear.
 In the present report, we examine the eosinophil 
chemotactic activity of extracts from nasal polyps in a 
patient with aspirin-induced asthma. We focus upon 
interleukin (IL)-5 as a chemoattractant because IL-5 is 
one of the key cytokines for eosinophil recruitment and 
activation.
CLINICAL SUMMARY
Case 1
A 45-year-old woman had suffered from chronic sinusitis 
for 6 years. After a right Caldwell-Luc operation 5 years 
ago, she developed bronchial asthma. Asthma attacks 
were worse when she took NSAID. The diagnosis of 
aspirin-induced asthma was made on the basis of 
hypersensitivity to acetylsalicylic acid (aspirin) at the 
Department of Respiratory Medicine, Kumamoto
University (Kumamoto, Japan). The patient was referred 
to our clinic for further examination. Rhinoscopy showed 
slightly hypertrophic middle turbinates and left nasal 
polyps. The patient's characteristics are shown in Table 1. 
Because of nasal blockage and watery rhinorrhea, 
she underwent endonasal sinus surgery (ESS). She had 
not received glucocorticosteroids for 3 months prior
to ESS. Polyps were removed, washed, homogenized 
with Polytron(R) (Kinematica, Switzerland) and were 
centrifuged at 20000g for 10min. The supernatant was
collected, filtered through a 0.45μm Millipore filter and
stored at-80℃ until use. Her nasal blockage improved
after ESS.
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Table 1. Patient characteristics
Case 2
A 63-year-old woman had suffered from chronic sinusitis 
and nasal polyps for 10 years. Although the onset of 
bronchial asthma had occurred at the age of 62, the 
patient's asthma condition was stable with the use of a 
topical corticosteroid and an oral bronchodilator. 
Aspirin-induced asthma was revealed after the patient 
took NSAID when polypotomy was performed. The 
patient's characteristics are shown in Table 1. As the 
patient complained of severe nasal blockage, another 
polypotomy was performed while she was free of asthma. 
The patient had not received glucocorticosteroids for 1 
month prior to polypotomy.
METHODS
Peripheral blood eosinophils were isolated by 
discontinuous Percoll density gradient centrifugation 
followed by negative selection with immunomagnetic 
beads, as previously described.4 Briefly, heparinized 
blood was separated by sedimentation of erythrocytes 
with dextran for 30min. The granulocyte rich fraction was 
centrifuged for 30min through Percoll to reduce the 
number of neutrophils. The eosinophil-rich fraction was 
collected and labeled with anti-CD16 monoclonal
antibody (mAb) for 45min at 4℃. Subsequently, cells
were washed twice with Hanks' balanced salt solution 
containing 2% fetal calf serum and were incubated with 
sheep anti-mouse immunomagnetic dynabeads (Dynal,
Great Neck, NY, USA) for 60min at 4℃. Neutrophils
were subsequently removed using a magnetic particle 
concentrator (MPCTH-1; Dynal). Eosinophil purity 
exceeded 95% and showed a viability greater than 98% 
as judged by trypan blue exclusion.
 Chemotactic activity was assessed by a modified 
Boyden chamber assay using 48-well microchemotaxis 
chambers (Neuro Probe, Cabin John, MD, USA) as 
previously described.5 In brief, cells were adjusted to
1×106 cells/mL in RPMI-1640 containing 10% fetal calf
serum (FCS) and 50μL was placed in the upper well,
which was separated from 29μL chemoattractont in the
lower well by a polyvinylpyrolidone-free nucleopore filter
(pore size 5μm). The chambers were incubated at 37℃
in 5% CO2 air for 90min. Following incubation, the filter 
was fixed with methanol and was stained with Diff-Quick, 
(Kokusai Shiyaku, Kobe, Japan). Cells that passed 
through the filter to the lower surface were counted using 
a 10mm eyepiece graticule in a light microscope using
400×magnification.
 Tissue extracts were prepared from nasal polyps of 
case 1 and were examined for the chemotactic response 
of the patient's peripheral blood eosinophils against 
these extracts. To determine whether IL-5 contributed to
this chemotactic response, 30μg/mL mAb against IL-5
(Genzyme, Boston, MA, USA) was added to the lower 
chamber. We used recombinant human (rh)IL-3 and rhlL-
5 i  the eosinophil chemotaxis assay. A pellet of the 
extract was resuspended in RPMI-1640 supplemented 
with 2% FCS, washed and centrifuged for 30min through 
Percoll. The lymphocyte-rich fraction was collected and 
was labeled with magnetic cell sorter (MACS) CD3 
Microbeads (Miltenyi Biotech, Bergisch Gladbach,
Germany) for 15min at 4℃. Subsequently, cells were
passed through the MACS (Miltenyi Biotech), and positive 
selection was performed according to the manufacturer's 
instructions. Purity of CD3+ cells exceeded 95%.
 Serum and extract concentrations of IL-5 were 
determined by an enzyme-linked immunosorbent assay 
(ELISA) according to procedures as described previously.6
ELISA plates (96 wells, lmmulon 4; Dynatech
Laboratories lnc., VA, USA) were coated with IL-5-specific
mAb (clone NC17, 2μg/mL in phosphate-buffered
saline (PBS), 100μL/well).7 After incubation overnight at
4℃,wells were washed three times with PBS/Tween, after
which 100μL aliquots of sample or standards were
added to each we l.After another overnight incubation at
4℃,wells were washed three times and 100μL rabbit
anti-human IL-5 serum was added to each well. After 
incubation for 4 h at room temperature, wells were
washed three times Gnd 100μL horserodish eroxidose-
conjugated goat anti-rabbit lgG (diluted 1:3000; Bio-
Rad, Hemel Hempstead, England) was added to each 
well. After incubation for 2 h at room temperature and 
washing, the chromogen was developed by adding the 
substrate O-phenylenediamine in the presence of 
0.015% hydrogen peroxide for 20min. Reactions were
stopped by adding 50μL of 2 mol/L sulfuric acid and the
optical densities (OD) were read at 490nm with an
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automated plate reader. The lower and upper limits of 
sensitivity of the assay were 100 and 40000pg/mL, 
respectively. No cross-reactivity was detected with IL-2, 
IL-3, IL-4, IL-6, or granulocyte-macrophage colony 
stimulating factor (GM-CSF). Standards were prepared 
from rhlL-5 purified on NC17-coupled beads from 
culture supernatants of Chinese hamster ovary cells 
transfected with human IL-5 cDNA.
 Total cellular RNA was extracted from T lymphocytes 
with Isogen, according to the protocol of Nippon Gene 
(Tokyo, Japan), a modified guanidium thiocyanate 
single-step procedure. After isolation, the RNA was
reverse transcribed in a total of 20μL reaction mixture
containing 50ng random hexamer (Gibco BRL Life 
Technologies Inc., Gaithersburg, MD, USA), 0.5mmol/L 
of each dNTP and 100 U Superscript reverse 
transcriptase (Gibco BRL) in 20mmol/L Tris. HCI (pH 
8.4), 50mmol/L KCI, 10mmol/L dithilthreitol and
2.5mmol/L MgCl2. The reaction was incubated at 42℃
for 50min, then at 95℃ for 5min and then chilled on
ice. cDNA was amplified in a 50μL reaction mixture
containing 50mmol/L KCI,10mmol/L Tris HCI (pH 8.8), 
1.5mmol/L MgCl2, 2.5 nmol of each dNTP, 25 pmol of 
each primer and 1.0 U of Taq polymerase (Perkin-Elmer 
Cetus, Norwalk, CA, USA). Nucleotide sequences for 
oligonucleotide 5'- and 3'-primers, respectively, were as
follows: β-actin, CTACAATGAGCTGCGTGTGG and
CGGTGAGGATCTTCATGAGG; IL-5, GCTTCTGCATT 
TGAGTTTGCTAGCT and TGGCCGTCAATGTATTTCTTT 
ATTAAG.8 The PCR was performed for 35 cycles (1min at
94℃,2min at 60℃,3min at 72℃). The PCR product
was electrophoresed in a 2% agarose gel in the presence 
of 0.5mg/mL ethidium bromide. The PCR product was 
transferred to a nylon membrane filter after degeneration 
with alkaline solution. Transferred DNA was fixed by 
UV-irradiation and hybridization was performed at
55℃ for 12h using a 32P-labeled internal probe
(GGCACTGCTTTCTACTCATCG).8 Peripheral blood 
lymphocytes from Kimura's disease and sterilized water 
were used as positive and negative controls for IL-5 
mRNA expression, respectively.
RESULTS
Peripheral blood eosinophils obtained from a patient 
(case 1) with aspirin-induced asthma showed an 
increased chemotactic response against tissue extracts in 
a dose-dependent pattern (Fig. 1). This chemotactic 
response was inhibited by 40% when an antibody against 
IL-5 was added (Fig. 2). As shown in Table 2, IL-5 was
Fig. 1 Chemotactic responses of blood eosinophils to nasal
polyp tissue extracts.
Fig. 2 Chemotactic responses of blood eosinophils to nasal 
polyp tissue extracts (1: 100 dilution) and the inhibitory effect 
of anti-IL-5 monoclonal antibody (mAb). The mAb against 
interleukin (IL)-5 was used at a concentration that neutralized 
10-9 mol/L IL-5 activity. Data represent the mean number 
of migrated cells/5 high power fields (h. p. f.) in duplicate.
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Fig. 3 Chemotactic response of blood eosinophils to
recombinant human interleukin (rhlL)-3 and rhlL-5.
Table 2. Concentration of interleukin-5
detected in polyp extracts from both case 1 and case 2. 
Although serum concentrations of IL-5 in three normal 
volunteers were undetectable (data not shown), one 
patient (case 1) had a serum concentration of IL-5 above 
the lower limit of the ELISA. Furthermore, IL-5 was not 
detected in polyp extracts nor in sera from two patients 
with chronic sinusitis that was not associated with aspirin-
induced asthma or allergic diseases (data not shown).
  Figure 3 shows the chemotactic response of 
eosinophils isolated from the peripheral blood of patients 
and from a healthy individual to rhlL-3 (10-9mol/L) and 
rhlL-5 (10-9mol/L). Eosinophils isolated from these patients 
showed an increased chemotactic response to rhlL-5 
compared with eosinophils from a normal subject. In 
contrast, chemotactic responses to rhlL-3 were increased 
both in asthmatic and in normal eosinophils.
Fig. 4 Southern blot analysis of RT-PCR from peripheral blood 
CD3+ cells (lane 1) and nasal polyp CD3+ cells (lane 2). 
Peripheral blood mononuclear cells from Kimura's disease were 
used as a positive control (lane 3) and sterilized water was used 
as a negative control (lane 4).
 Messenger RNA for IL-5 was detectable in CD3+ T 
lymphocytes from nasal polyps but not from peripheral 
blood, as shown in Fig. 4.
DISCUSSION
Nasal polyps in aspirin-induced asthma are characterized 
by infiltration of inflammatory cells, especially 
eosinophils.1-3 In addition, immunohistochemical studies 
have demonstrated that most of these eosinophils are 
activated (EG2+ cells).3 Picado et al.9 have found a
significant increase in peptide leukotrienes in aspirin-
induc d asthma patients 60min after nasal challenge. 
These findings suggest that activated eosinophils may be 
involved in nasal symptoms and polyp formation because 
eosin phils can produce peptide leukotriene.10 However, 
the mechanism of eosinophil recruitment into nasal polyp 
tissue has not been clarified.
 Rece t studies have suggested that T lymphocytes play 
an important role in allergic inflammation, especially for 
recruitment and activation of eosinophils. In situ 
hybridization studies of biopsies of human skin and nose
have revealed significant increases in cells expressing 
mRNA for IL-4, IL-5 and GM-CSF in late-phase 
reactions.11-12 In addition, a significant correlation has 
been found between the number of EG2+ cells and IL-5 
mRNA+ cells in late nasal responses.12 Accordingly, we 
examined IL-5 in nasal polyp tissue.
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 We detected eosinophil chemotactic activity in extracts 
of nasal polyps in case 1 and found that this activity was 
inhibited by the antibody against IL-5. Interleukin-5 was 
also detectable in nasal polyp extracts in these cases.
Furthermore, rhlL-5 had a higher chemotactic activity 
against the patients' peripheral blood eosinophils 
compared with normal eosinophils. By using RT PCR, we 
observed the expression of mRNA for IL-5 in CD3+ T 
lymphocytes from polyp tissue but not from peripheral 
blood.
Interleukin-5 is considered to be a weak chemo-
attractant for normal eosinophils; however, an IL-5 
response was not found for peripheral blood eosinophils
from bronchial asthma patients.13 Conversely, peripheral 
blood eosinophils of patients with allergic rhinitis exhibit a 
higher locomotory response towards IL-5 than do normal 
subjects.14 We have also found a higher chemotactic
activity of eosinophils in patients with Kimura's disease 
towards IL-5.15 These findings suggest that there may be 
heterogeneity in the eosinophil response to IL-5, but this 
has not been confirmed.
 We were not able to completely inhibit the chemotactic 
response of peripheral blood eosinophils against tissue 
extracts with anti-IL-5 antibody. Recent studies have shown 
that the synergism between IL-5 and eotaxin will induce the 
recruitment of eosinophils in inflammatory sites in guinea
pigs.16 Taken together, chemokines other than IL-5 may 
also be involved in the recruitment of eosinophils in 
aspirin-induced asthma. Further study is required to 
identify the eosinophil chemoattractants, other than IL-5, 
in nasal polyps in aspirin-induced asthma.
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